Lv5
846 积分 2024-05-27 加入
Development of Integrin-Facilitated Bispecific Aptamer Chimeras for Membrane Protein Degradation
1天前
已完结
Intelligent DNA Nanosystem for Broad-Spectrum Oncological Typing and Therapy
1个月前
已完结
Securing LYTAC with Logic-Identification System for Cancer Cell-Selective Membrane Protein Degradation
1个月前
已完结
Chemical Evolution of Double Covalent Aptamers for Sustained Protein Degradation and Improved Cytotoxicity in NK-Cell-Mediated Tumor Therapy
1个月前
已完结
Targeted RNA Degradation via LipoSM-RiboTAC Nanoparticles: A Versatile Platform for Cancer Therapy
1个月前
已完结
Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation
1个月前
已完结
HSP90 Mediates Targeted Degradation of Nonclient Protein PARP1 for Breast Cancer Treatment
2个月前
已完结
Highly Specific Cytokine Receptor-Targeting Chimeras for Targeted Membrane Protein Degradation and Sensitization of Osimertinib in EGFR-Mutated Non-Small-Cell Lung Cancer
2个月前
已完结
Aptamer-RIBOTAC Strategy Enabling Tumor-Specific Targeted Degradation of MicroRNA for Precise Cancer Therapy
2个月前
已完结
皖公网安备34019202002308
